Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Angi Inc. (ANGI) - free report >>
Zymeworks Inc. (ZYME) - free report >>
Stitch Fix, Inc. (SFIX) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Angi Inc. (ANGI) - free report >>
Zymeworks Inc. (ZYME) - free report >>
Stitch Fix, Inc. (SFIX) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 26th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Angi Inc. (ANGI - Free Report) : This company which connects consumers with home service professionals has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
Angi Inc. Price and Consensus
Angi Inc. price-consensus-chart | Angi Inc. Quote
Stitch Fix, Inc.(SFIX - Free Report) : This fashion apparel Retailer has seen the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.
Stitch Fix, Inc. Price and Consensus
Stitch Fix, Inc. price-consensus-chart | Stitch Fix, Inc. Quote
Zevia PBC (ZVIA - Free Report) : This beverage company has seen the Zacks Consensus Estimate for its current year earnings increasing 13.5% over the last 60 days.
Zevia PBC Price and Consensus
Zevia PBC price-consensus-chart | Zevia PBC Quote
Zymeworks Inc. (ZYME - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.5% over the last 60 days.
Zymeworks Inc. Price and Consensus
Zymeworks Inc. price-consensus-chart | Zymeworks Inc. Quote
Werewolf Therapeutics, Inc. (HOWL - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Werewolf Therapeutics, Inc. Price and Consensus
Werewolf Therapeutics, Inc. price-consensus-chart | Werewolf Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.